TREM2 and Alzheimer disease: TREM2 is also expressed in osteoclasts and, in addition to modulating AD-risk, TREM2 mutations cause frontotemporal dementia or Nasu-Hakola disease, a rare neurogenerative disorder with bone involvement and white matter loss9.